Epigenetic and functional analysis of IGFBP3 and IGFBPrP1 in cellular immortalization

Biochemical and Biophysical Research Communications

Volumn 357, Issue 3, 2007, Pages 785-791

  Fridman, Aviva Levine ^a   Rosati, Rita ^a   Li, Qunfang ^a   Tainsky, Michael A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 aza dC; CpG island; DNA methylation; Epigenetic silencing; IGFBP3; IGFBP4; IGFBPrP1; Immortalization; Interferon

Indexed keywords

5 AZA DEOXYCYTIDINE; CONNECTIVE TISSUE GROWTH FACTOR; CYTIDINE DERIVATIVE; PROTEIN IGFBP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; CPG ISLAND; DNA FINGERPRINTING; EPIGENETICS; GENE CLUSTER; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; METHYLATION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AZACITIDINE; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERFERON-ALPHA; LI-FRAUMENI SYNDROME; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34247521778     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.019     Document Type: Article

References (25)

1. Yu H., and Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92 (2000) 1472-1489
2. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824-854
3. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20 (1999) 761-787
4. Lopez-Bermejo A., Buckway C.K., Devi G.R., Hwa V., Plymate S.R., Oh Y., and Rosenfeld R.G. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology 141 (2000) 4072-4080
5. Swisshelm K., Ryan K., Tsuchiya K., and Sager R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA 92 (1995) 4472-4476
6. Tomii K., Tsukuda K., Toyooka S., Dote H., Hanafusa T., Asano H., Naitou M., Doihara H., Kisimoto T., Katayama H., Pass H.I., Date H., and Shimizu N. Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int. J. Cancer 120 (2007) 566-573
7. J. Lin, M. Lai, Q. Huang, Y. Ma, J. Cui, W, Ruan, Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression, J. Pathol. (2007).
8. Ibanez de Caceres I., Dulaimi E., Hoffman A.M., Al-Saleem T., Uzzo R.G., and Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 66 (2006) 5021-5028
9. Wiley A., Katsaros D., Chen H., Rigault de la Longrais I.A., Beeghly A., Puopolo M., Singal R., Zhang Y., Amoako A., Zelterman D., and Yu H. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer 107 (2006) 299-308
10. Hanafusa T., Yumoto Y., Nouso K., Nakatsukasa H., Onishi T., Fujikawa T., Taniyama M., Nakamura S., Uemura M., Takuma Y., Yumoto E., Higashi T., and Tsuji T. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett. 176 (2002) 149-158
11. Shelton D.N., Chang E., Whittier P.S., Choi D., and Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 9 (1999) 939-945
12. Goldstein S., Moerman E.J., Jones R.A., and Baxter R.C. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc. Natl. Acad. Sci. USA 88 (1991) 9680-9684
13. Schwarze S.R., DePrimo S.E., Grabert L.M., Fu V.X., Brooks J.D., and Jarrard D.F. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277 (2002) 14877-14883
14. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., and Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. USA 99 (2002) 389-394
15. Wilson H.M., Birnbaum R.S., Poot M., Quinn L.S., and Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ. 13 (2002) 205-213
16. Fridman A.L., Tang L., Kulaeva O.I., Ye B., Li Q., Nahhas F., Roberts P.C., Land S.J., Abrams J., and Tainsky M.A. Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton. J. Gerontol. A. Biol. Sci. Med. Sci. 61 (2006) 879-889
17. Kulaeva O.I., Draghici S., Tang L., Kraniak J.M., Land S.J., and Tainsky M.A. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 22 (2003) 4118-4127
18. Gollahon L.S., Kraus E., Wu T.A., Yim S.O., Strong L.C., Shay J.W., and Tainsky M.A. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17 (1998) 709-717
19. Q. Li, L. Tang, P. C. Roberts, J. M. Kraniak, A. L. Fridman, O. I. Kulaeva, O. S. Tehrani, M. A. Tainsky, Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts, submitted for publication.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
21. Friedlander P., Haupt Y., Prives C., and Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16 (1996) 4961-4971
22. Werner H., Karnieli E., Rauscher F.J., and LeRoith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 93 (1996) 8318-8323
23. Kang M.K., Kameta A., Shin K.H., Baluda M.A., Kim H.R., and Park N.H. Senescence-associated genes in normal human oral keratinocytes. Exp. Cell Res. 287 (2003) 272-281
24. Del Monte P., Laurino C., Arvigo M., Palermo C., Minuto F., and Barreca A. Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. J. Endocrinol. Invest. 28 (2005) 432-439
25. Moser D.R., Lowe Jr. W.L., Dake B.L., Booth B.A., Boes M., Clemmons D.R., and Bar R.S. Endothelial cells express insulin-like growth factor-binding proteins 2 to 6. Mol. Endocrinol. 6 (1992) 1805-1814